What the six lenses say about TORNTPHARM — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How TORNTPHARM’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Large-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +0.3pp | +6.0pp | +6.5pp | +18.2pp | +30.3pp | +52.2pp |
Nifty 500 Broad-market baseline | -0.1pp | +5.9pp | +5.9pp | +14.6pp | +25.2pp | +48.3pp |
Sector Own-sector index | — | — | +3.5pp | +2.1pp | +10.9pp | +30.5pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
TORNTPHARM daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
TORNTPHARM ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 2,859 | 2,889 | 2,809 | 2,959 | 3,178 | 3,302 | 3,303 | 4,197 |
| ↳ change QoQ | — | +1.0% | -2.8% | +5.3% | +7.4% | +3.9% | +0.0% | +27.1% |
| EBITDA (₹cr) | 928 | 923 | 947 | 964 | 1,032 | 1,083 | 1,088 | 1,356 |
| EBITDA margin | 32.5% | 31.9% | 33.7% | 32.6% | 32.5% | 32.8% | 32.9% | 32.3% |
| PAT (₹cr) | 457 | 453 | 503 | 498 | 548 | 591 | 635 | 364 |
| ↳ change QoQ | — | -0.9% | +11.0% | -1.0% | +10.0% | +7.8% | +7.4% | -42.7% |
| Net margin | 16.0% | 15.7% | 17.9% | 16.8% | 17.2% | 17.9% | 19.2% | 8.7% |
| EPS (₹) | 13.51 | 13.37 | 14.88 | 14.71 | 16.19 | 17.46 | 18.76 | 10.76 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A dividend declaration — a cash return to shareholders.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding TORNTPHARM (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| HDFC Large Cap Gr | 3.71% | 37,808 | |
| Axis Large Cap Fund Gr | 1.03% | 30,005 | |
| HDFC Large and Mid Cap Gr | 0.52% | 28,515 | |
| UTI Flexi Cap Reg Gr | 1.40% | 22,882 | |
| Canara Robeco Large Cap Reg Gr | 0.95% | 16,692 | |
| Axis Large & Mid Cap Reg Gr | 1.08% | 15,879 | |
| Kotak Large Cap Reg Gr | 1.61% | 10,772 | |
| Franklin India Large Cap Gr | 1.49% | 7,145 | |
| Helios Flexi Cap Reg Gr | 1.60% | 7,094 | |
| Aditya BSL Consumption Gr | 1.40% | 5,843 |
ETFs holding TORNTPHARM (10)